Reducing Post-Hospital Mortality in HIV-infected Adults in Tanzania
NCT ID: NCT03858998
Last Updated: 2025-04-23
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
500 participants
INTERVENTIONAL
2019-03-05
2024-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Geriatric HIV Cohort in Sub Sahara Africa
NCT04313699
Regional Differences in Human Immunodeficiency Virus (HIV) Testing
NCT03158987
Acute Coronary Syndrome KCMC_1
NCT06503991
The Impact of Structured Exercise on Brain Health in HIV Positive Individuals
NCT03053817
SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy
NCT05586581
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondary outcome measures time frames have been updated to add the 24-month time point for consistency with the pre-specified endpoints in the study protocol.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case Management Intervention
A 90-day case management intervention to link hospitalized HIV-infected participants with local HIV clinics.
Case Management Intervention
A 90-day case management intervention to link hospitalized HIV-infected participants with local HIV clinics.
Control
Current routine HIV care in Tanzania.
Control
Current routine HIV care in Tanzania.
Control
Current routine HIV care in Tanzania.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Case Management Intervention
A 90-day case management intervention to link hospitalized HIV-infected participants with local HIV clinics.
Control
Current routine HIV care in Tanzania.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HIV-infected
* ART (anti-retroviral therapy) naïve or have been on ART but have not used ART for \> 7 days
* Lives in the region of Mwanza
* Able to be referred to an HIV clinic inside the region of Mwanza
* Has mobile phone or access to mobile phone
* Planning to stay in the region of Mwanza for the next 24 months
* Able to speak Kiswahili or English
* Capable and willing to provide informed consent
* Willing to provide locator information and two designated contact persons
* Willing to have a home visits from a study team member
Exclusion Criteria
* On anti-retrovirals at hospital admission and already linked to an HIV clinic
* Medical, psychiatric or psychological condition that, in the opinion of the site investigator, would interfere with completion of study procedures
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Weill Medical College of Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Peck, MD
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Busisi Health Center
Busisi, Mwanza Region, Tanzania
Magu District Hospital
Magu, Mwanza Region, Tanzania
Nyamilama Health Center
Nyamilama, Mwanza Region, Tanzania
Sengerema Health Center
Sengerema, Mwanza Region, Tanzania
Bugando Medical Center
Mwanza, , Tanzania
Bukumbi Hospital
Mwanza, , Tanzania
Buzuruga Health Center
Mwanza, , Tanzania
Evangelical Lutheran Church in Tanzania (ELCT) Health Centre
Mwanza, , Tanzania
Igoma Health Centre
Mwanza, , Tanzania
Karume Health Centre
Mwanza, , Tanzania
Kwimba District Hospital
Mwanza, , Tanzania
Misungwi District Hospital
Mwanza, , Tanzania
Nyamagana District Hospital
Mwanza, , Tanzania
Sekou Toure Hospital
Mwanza, , Tanzania
Sengerema District Hospital
Mwanza, , Tanzania
Seventh Day Adventist (SDA) Health Centre
Mwanza, , Tanzania
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Okello ES, Peck RN, Issarow B, Kisigo G, Abel K, Malibwa D, Kabakama S, Charles M, Lee M, Rutachunzibwa T, Fitzgerald D, Ayieko P, Grosskurth H, Metsch LR, Kapiga S. "Ashamed of being seen in an HIV clinic": a qualitative analysis of barriers to engaging in HIV care from the perspectives of patients and healthcare workers in the Daraja clinical trial. BMC Public Health. 2025 Jan 7;25(1):69. doi: 10.1186/s12889-024-21231-z.
Peck RN, Issarow B, Kisigo GA, Kabakama S, Okello E, Rutachunzibwa T, Willkens M, Deogratias D, Hashim R, Grosskurth H, Fitzgerald DW, Ayieko P, Lee MH, Murphy SM, Metsch LR, Kapiga S. Linkage Case Management and Posthospitalization Outcomes in People With HIV: The Daraja Randomized Clinical Trial. JAMA. 2024 Mar 26;331(12):1025-1034. doi: 10.1001/jama.2024.2177.
Kisigo GA, Issarow B, Abel K, Hashim R, Okello ES, Ayieko P, Lee MH, Grosskurth H, Fitzgerald D, Peck RN, Kapiga S. A social worker intervention to reduce post-hospital mortality in HIV-infected adults in Tanzania (Daraja): Study protocol for a randomized controlled trial. Contemp Clin Trials. 2022 Feb;113:106680. doi: 10.1016/j.cct.2022.106680. Epub 2022 Jan 13.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1804019134
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.